In recent surface proteomics studies, CCR1 has emerged as one of the top six MM surface antigens, exhibiting high expression in samples from R/R MM patients and undetectable-to-minimal expression in normal tissues [14]. Here, CCR1 is linked to Miyoshi myopathy.